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Abstract

THE EFFECTS OF EXERCISE ON PRESSURE NATRIURESIS
JANET KOMOLAFE
A THESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE
REQUIREMENTS FOR THE DEGREE OF
MASTER OF SCIENCE IN BIOLOGY
MINNESOTA STATE UNIVERSITY, MANKATO
MANKATO, MINNESOTA
JULY 2020.
Hypertension is a disease of high global burden and a leading risk factor for
cardiovascular diseases and related deaths. The pressure natriuresis
mechanism, which is an intrinsic response in the kidneys which increases
urinary sodium excretion when renal perfusion pressure increases, plays a
central role in the long-term regulation of mean arterial pressure. Studies have
shown that a sustained impairment of the pressure natriuresis mechanism
results in high blood pressure, making hypertension a disease of the kidneys.
Since exercise is recommended as a non-pharmacological treatment to
manage hypertension, it is important to understand the means by which
exercise is beneficial in hypertensive patients. Since pressure natriuresis is a
key component in the regulation of blood pressure, understanding the
relationship between exercise and pressure natriuresis is important. This
study was designed to determine if voluntary exercise in young normotensive
rats (from weaning to adulthood), altered pressure natriuresis.
Thirty-six (36) WKY, normotensive rats were set up into two (2) groups;
sedentary (8 males & 8 females) and exercised (10 males & 10 females).
Each rat had urinary sodium excretion measured at variable renal perfusion
pressures (RPP) - baseline, lowered, and raised. Sodium excretion was
measured and plotted against RPP to generate a pressure-natriuresis curve.
Both male and female rats, (exercised and sedentary) had significant
natriuresis responses to increases in RPP, but the response was greater in
female rats than males. Exercise improved the pressure natriuresis
relationship in both males and females, resulting in a steeper slope of the
pressure natriuresis curve. This means that exercised rats had a greater
increase in sodium excretion for any given increase in RPP. Our findings
therefore demonstrated that exercise improves the pressure natriuresis
relationship in both male and female rats, and this may partially explain the
beneficial effects of exercise in hypertensive patients.
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Introduction
Hypertension (also called high blood pressure) is the leading risk factor
contributing to the global burden of cardiovascular disease (59). The
American Heart Association, in 2018, estimated that 103 million Americans
(31.5% of the population) have hypertension. In 2019, the World Health
Organization released a global statistic on hypertension and stated that
almost 1.3 billion (17%) of the world population is hypertensive and it is
projected that more than 1.5 billion people will develop hypertension by 2025
(49).
According to the guidelines given in 2017 by the American College of
Cardiology and the American Heart Association for the prevention, detection,
evaluation and management of high blood pressure, hypertension is now
defined as systolic blood pressure of greater than or equal to 130mmHg and
diastolic blood pressure of greater than or equal to 80mmHg (104).
Hypertension directly poses a great public health challenge due to the
associated systemic complications including stroke, blindness, kidney
diseases, and heart diseases like myocardial infarction, angina, and heart
failure, and contributes to about 12 million annual deaths worldwide. It is the
major modifiable risk factor for developing cardiovascular and renal disease
and there is no cut off for risk, which doubles with every 20 mmHg increase in
systolic blood pressure (58). It is also important to note that hypertension is
often a preventable and treatable disease (74).
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Blood Pressure (BP) is the product of cardiac output (CO) and total peripheral
resistance (TPR), and CO is the product of heart rate and stroke volume.
Heart rate is the number of heart beats per minute while stroke volume is the
volume of blood pumped from the left ventricle per beat. Peripheral vascular
resistance is the resistance to flow through the blood vessels.
To maintain a normal BP, there must be a balance between the cardiac output
and peripheral vascular resistance. Blood pressure increases with increased
blood volume and cardiac output as well as increased blood viscosity and
peripheral vascular resistance. Blood volume may be increased through
excessive sodium intake, or from increased sodium and water retention from
hormonal influences (aldosterone, antidiuretic hormone) or from chronic renal,
cardiovascular or liver diseases. Any condition that increases heart rate, such
as heart disease, thyroid disease, infections or side effect of certain
medications, can also increase the cardiac output which increases blood
pressure (8, 52).
Peripheral vascular resistance is influenced by the sympathetic nervous
system (SNS), humoral factors, and local autoregulation. Increased vascular
resistance may occur due to increased blood viscosity, endothelial
dysfunction or rigidity of vessel walls from aging, atherosclerosis and other
peripheral artery diseases through oxidative stress and vascular inflammation
(17, 98). It is also elevated following increased sympathetic activity and in the
presence of chemical substances such as endothelin, angiotensin II. The
relationship between heart rate, stroke volume and peripheral resistance
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explains why studies on hypertension have centered around cardiac or
vascular theories (46). While blood pressure parameters are usually linked to
the cardiovascular system, renal mechanisms have also been implicated in
the long-term control of blood pressure regulation, especially the pressure
natriuresis mechanism. The cardiovascular system depends on the kidneys
for sodium and water balance in the body. It is thought that the pressure
natriuresis system is the dominant method of controlling BP on a long-term
basis and that it can compensate for other mechanisms that may cause
hypertension such as, increased vascular resistance. This indicates that
sustained impairment of pressure natriuresis will result in elevated blood
pressure making hypertension is also a disease of the kidneys (96).
There is no known specific cause of hypertension, it is categorized as a
multifactorial disease involving an interplay of genetic, environmental,
vascular, neuronal and endocrine factors (70, 84).There is no known specific
cause of hypertension, it is categorized as a multifactorial disease involving
an interplay of genetic, environmental, vascular, neuronal and endocrine
factors (70, 84).
Generally, the risks of developing hypertension are classified as modifiable
and non-modifiable. Modifiable risks include physical inactivity, high salt
intake, high saturated fat intake, smoking, alcohol consumption, and stress.
Non-modifiable risks are those over which the individual has no control, and
they include age, gender (more common in males), family history of
hypertension, and race (more common in blacks) (104). Other risk factors
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include presence of comorbidities like diabetes mellitus, chronic renal
diseases, adrenal diseases, and thyroid diseases. (80).
The symptoms include, but are not limited to, headaches frequently noticed in
the morning, eye ache or blurry vision, chest pain, palpitation, nosebleed,
dizziness, and muscle tremors. However, many people are unaware of their
condition as they tend to remain asymptomatic for a while and may only
present when complications set in. Therefore, the disease is also referred to
as a silent killer (34).
Treatments include lifestyle changes aimed at improving the modifiable risks,
pharmacological and non-pharmacological (or surgical) options. The goal of
treatment is not to aggressively reduce blood pressure as that could be
detrimental, but to gradually lower it and work towards preventing
complications and limiting adverse cardiovascular events and deaths (109).
About 15% of hypertensive patients fail to reach target blood pressure ranges,
despite the use of up to three antihypertensive medications of different
classes (76). It is also very difficult to accurately predict which type of
antihypertensive medication will be most appropriate for each patient due to
the multiple causative factors that may be involved.
As beneficial as the pharmacological approach is in the treatment of
hypertension, the advantage of non-pharmacological prevention or
management cannot be overemphasized (7). Exercise is often prescribed as
a non-pharmacological treatment or prevention for hypertension. Exercising
consistently for as little as 1 day per week (up to 30 minutes) has been shown
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to be effective in reducing mortality among those with hypertension (7, 28).
However, the physiology behind the beneficial effects of exercise in lowering
blood pressure is not well understood.
Since the kidneys play a key role in blood pressure regulation, it is reasonable
to postulate that exercise may affect kidney physiology. This study sought to
determine if exercise alters kidney-salt regulation, elucidating a potential
means by which exercise is beneficial to hypertensive patients.

Literature review
Hypertension
Epidemiology
The prevalence of hypertension increases with age and it is mainly related to
vascular changes such as calcification and stiffness associated with ageing
(77). It is found to be more common in men than women. The reason is
believed to be the lack of endogenous estrogen which is important for normal
endothelial functioning, and the presence of testosterone in males (4).
Supporting the role of estrogen in hypertension is the higher prevalence of
hypertension in postmenopausal women when compared to men of the same
age group (13, 21, 27, 104).
A study conducted by Hu et al on hypertension in Southern China showed
that the prevalence was slightly higher in males than females, and it increased
with age in both genders. They also recorded more cases of hypertension
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among obese patients, whether male or female. More postmenopausal
women were found to be hypertensive then men in the same age group (45).
It is thought to be due to the estrogen deficiency after menopause, which
results in endothelial impairment (94). Similarly, a cross-sectional study
conducted by Khanal et al in Nepal in which the ratio of male to female
participants was 30:70 with an average age of 47 years, showed that the
prevalence of hypertension was higher among men (up to 50% of recorded
cases). About 60% of the hypertensive patients were males and females over
the age of 60 years, further showing that hypertension increases with age.
Obesity, smoking and alcohol consumption were other factors that were
directly linked to hypertension among the participants (51).
To ascertain if differences in the prevalence of hypertension between genders
occur earlier in life, a study conducted among young adults in the United
States showed distinctions in the risk and prevalence of hypertension
between genders as early as 20 years of age (21). As with other studies, they
observed fewer cases of hypertension among premenopausal women. The
researchers also proposed that these differences may be due to biological
differences between the genders, or behavioral patterns such as sedentary
lifestyle (higher in females), smoking (higher in males), and healthcare
seeking attitudes (higher in females).
Several sex and age-related studies on hypertension have also been
conducted on lab animals. A study by Saez et al examined in rats the effect of
early onset disruption of renal development on the risk of developing
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hypertension later in life. They induced nephron loss in the treatment group
(consisting of males and females) by administering AT II receptor antagonist
orally within 14 days of postnatal life. The rats were studied after a year, and
they observed deterioration of renal structure and function in both sexes, but it
was significantly higher in the male treated rats. This deterioration was
characterized by reduced glomerular filtration rate, proteinuria, thickened
glomerular basement membrane and progressively elevated blood
pressure(85).
Classification
Hypertension can be classified into 2 main categories: essential and
secondary.
Essential hypertension is also called primary or idiopathic. It is defined as
elevated blood pressure with no identifiable or diagnosed underlying diseased
condition. It is so called because it has a slow onset and is usually
asymptomatic and long standing. The patients usually present with
complications by the time it is diagnosed. It is the most common type of
hypertension, accounting for about 95% of hypertensive cases worldwide (3,
38). The baseline abnormality in essential hypertension seems to be a
primary dysfunction of the pressure natriuresis relationship (6). In some
cases, it is linked to genetic (polygenic) factors, in which case it is called
inheritable blood pressure. In other cases, it is related to modifiable
(hypertensinogenic) factors like obesity/sedentary lifestyle, increased salt, and
alcohol intake etc. Children’s risks of developing hypertension may be
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increased due to non-modifiable factors that include prematurity, and low birth
weight, and modifiable factors like secondary smoke exposure and poor sleep
(10, 22). Most researchers believe that essential hypertension is due to a
combination of genetic and environmental factors (48).
Secondary hypertension occurs due to an underlying disease condition and
may have multiple etiologies. It accounts for less than 5% of hypertensive
cases and it is associated with early onset development of hypertension. With
genetic involvement, there is a monogenic mutation within the renal and
adrenal systems, leading to a disruption of sodium regulation and blood
pressure control (10, 82).
Children and adolescents are more prone to developing secondary
hypertension (more than 50% of pediatric hypertension) and it has been
linked mostly to renal diseases/tumors, cardiovascular and endocrine
diseases (23, 73).
Blood pressure and autoregulatory mechanisms
For the cardiovascular system to function appropriately, the systemic arterial
pressure must be maintained within normal limits. In each cardiac cycle,
arterial blood pressure fluctuates between diastolic and systolic pressures and
is controlled by autoregulatory mechanisms to keep it at homeostatic levels.
The regulation is achieved by the interdependence of the 3 parameters that
make up blood pressure: Heart rate (HR), ventricular stroke volume (SV) and
total peripheral vascular resistance (TPVR) (2). These adjustments can either
be short-term (seconds to minutes) or long-term (minutes to days). Short-term
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regulation of arterial blood pressure is primarily by baroreceptor and
chemoreceptor mechanisms, through the activity of the autonomic nervous
system. Long-term regulation is of high clinical importance because of the
prevalence of hypertension, and mainly involves the regulation of extracellular
fluid volume (ECFV) by sodium regulatory mechanisms involving the kidney,
including the widespread actions of angiotensin II and aldosterone (2). Blood
volume is an important determinant of blood pressure as it affects the cardiac
output. Blood volume itself is controlled by the ECFV, which is a function of
the balance between sodium and water intake and elimination, mainly by the
kidneys. Sodium is an osmotically active substance and will always be
accompanied by water, whether it is being reabsorbed into the body or
excreted into the urine. Thus, effective circulating volume is a function of body
sodium regulation and is dependent on an interplay of hormones and Starling
capillary forces (61, 89). An increase in body sodium and water causes an
increase in body fluid volume and an increase in blood volume. Increased
circulating blood volume results in increased peripheral venous pressure and
venous return. Central venous pressure also becomes elevated following an
increase in venous return, which results in increased end diastolic volume,
stroke volume, cardiac output and blood pressure (61, 89, 97). Increased
circulating volume also increases renal perfusion pressure (RPP) which
inhibits renin secretion and the renin-angiotensin-aldosterone system (RAAS).
Peritubular capillary hydrostatic pressure also increases leading to increased
filtration in the renal medulla and reduced tubular reabsorption of salt and
water. The resultant effect is increased sodium and water excretion which
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reduces circulating volume, venous return, stroke volume and finally reduces
the cardiac output and blood pressure to homeostatic levels (61, 89).
Reduced effective circulating volume (e.g. from dehydration or hemorrhage)
has an opposite effect by reducing renal perfusion pressure which stimulates
renin release to activate the RAAS pathway (further details in sodium
regulation section). This causes increased reabsorption of sodium and water
in the kidneys, due to the effects of aldosterone and antidiuretic hormone.
Sodium retention causes an expansion of ECFV which in turn increases blood
volume, stroke volume and cardiac output to raise the blood pressure back to
the normal homeostatic level. There is also a reduction in capillary hydrostatic
pressure in the renal medulla, which reduces filtration and increases sodium
reabsorption causing increased blood volume and blood pressure (61, 89).
Sodium Regulation
The kidneys are paired bean-shaped retroperitoneal organs and are one of
the most vital organs, central to homeostatic processes in the body. In
addition to regulating blood pressure through sodium regulation, they are
involved in toxin and waste (urine) excretion, reabsorption of electrolytes
including Na+, K+, and Cl-, regulation of plasma pH and osmolality, and
hormone production (renin, erythropoietin and vitamin D) (25, 95).
The kidneys receive more than 20% of the CO through the renal artery, and
this rich blood supply is essential for renal functions. The functional unit of the
kidney is the nephron and there are about 3 million of these in both kidneys.
Each nephron is made up of a renal corpuscle and a renal tubule. The renal
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corpuscle consists of the glomerulus (a network of capillaries) enclosed by a
glomerular or Bowman’s capsule. The glomerulus, by pushing fluid through
capillary pores, produces a filtrate that passes through the rest of the nephron
to become urine. The renal tubule is made up of the proximal convoluted
tubule (PCT), loop of Henle, distal convoluted tubule (DCT) and collecting
duct. The PCT is important for selective reabsorption of water, sodium,
glucose, and amino acids that entered the filtrate. The loop of Henle is a Ushaped tubule involved in concentrating the renal interstitium through a
countercurrent mechanism involving salt and water. DCT reabsorbs Na+ and
Cl- from the filtrate, and secretes K+, and these processes are regulated by
the hormone aldosterone. It may also reabsorb less Na+ in the presence of
natriuretic substances like ANP (69).
Regulation of sodium and body fluid volume is predominantly by the RAAS
and pressure natriuresis mechanisms while sympathetic nervous control and
natriuretic peptides make minor contributions (12).
Natriuretic peptides
Natriuretic peptides are endogenous hormones involved in natriuresis and
diuresis. They are commonly grouped as cardiac or renal. The cardiac
peptides are atrial natriuretic peptide (ANP) and brain natriuretic peptide
(BNP). ANP is mainly produced within the atria (47). BNP is mainly produced
in the ventricles (88). ANP is usually secreted at a physiologically low
concentration in response to atrial stretch. BNP is released with myocardial
stretch. Both ANP and BNP can also be secreted in response to pressor
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hormones such as epinephrine, phenylephrine, and angiotensin II (47, 65,
79). Both exhibit cardiac and renal protective properties and can mediate
natriuresis, diuresis, increased glomerular filtration rate, reduction of reninangiotensin activity, and increased cardiac output (65, 78, 79). However, they
are quickly degraded from the system by an enzyme called neprilysin. BNP is
reported to have a half life of about 20 minutes and ANP, about 7 minutes (16,
47, 99, 103).
The renal natriuretic peptide – urodilatin is structurally and functionally like
ANP (1, 24). Urodilatin is secreted from the distal tubules of the kidneys in a
circadian fashion and is influenced by increased dietary sodium intake or
acute saline infusion (24, 30). Some studies have also shown that the
synthesis of urodilatin is affected by cardiac sympathetic nerves (1, 33). Like
the cardiac natriuretic peptides, urodilatin also has a very short half-life (11).
Sympathetic Nervous Control
The sympathetic nervous system (SNS) is involved in short- and long-term
regulation of blood pressure. On a short-term basis, the sympathetic nerves
are influenced by arterial baroreceptors which sense pressure changes in the
arteries (60). A decrease in BP causes reduced baroreceptor firing which
stimulates cardiac sympathetic drive and reduces vagal tone, resulting in
increased firing from the sinoatrial node of the heart, and increased heart rate.
Increased sympathetic activity also increases ventricular contractility which
increases stroke volume and cardiac output. These combined effects restore
BP to a normal level (60).
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Long term regulation of BP by the SNS involves sodium regulation. It is
thought that SNS nerves in the kidneys directly facilitate sodium and water
reabsorption in the tubules, thus reduction in sympathetic outflow will result in
increased sodium excretion and vice versa (61). Renin activity is also linked to
sympathetic activity such that reduced sympathetic activity causes reduced
renin secretion with reduced plasma angiotensin II formation. This leads to
reduced sodium and water retention and increased salt and water excretion
(12, 60, 61).
Renin-Angiotensin-Aldosterone System
The Renin-Angiotensin-Aldosterone system (RAAS) is an important hormonal
system that mainly regulates BP by controlling water and electrolyte
homeostasis and it significantly modulates pressure natriuresis (19, 35, 44).
As the name implies, there are 3 hormones involved in this system. Renin, a
protease enzyme, is the rate-limiting enzyme and it is secreted by the
juxtaglomerular cells of the kidneys. Synthesis of renin is directly influenced
by increased sympathetic outflow via the beta-2 receptor, (as mentioned
above in sympathetic nervous control), decreased renal perfusion pressure,
reduced Na+ delivery to the macula densa of the DCT, presence of
prostaglandins, nitric oxide, adenosine and other mediators. (12, 61).
Conversely, endothelin has been found to inhibit renin secretion (12).
Once renin is released, it acts on the renin substrate – angiotensinogen, a
peptide hormone synthesized in the liver. Renin converts angiotensinogen to
angiotensin I (AT I). AT I is then converted to Angiotensin II (AT II) by
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angiotensin-converting enzyme (ACE), located on the lung endothelium
(mainly) and kidney epithelial cells (12, 25, 61).
AT II is a potent vasoconstrictor which maintains or increases systemic blood
pressure, as needed, by increasing peripheral vascular resistance. It also
stimulates the release of aldosterone and antidiuretic hormone. These
hormones stimulate sodium retention and thirst, respectively, to expand body
fluid volume, CO and ultimately BP (25, 61). Both angiotensin and
aldosterone have anti-natriuretic effects. AT II binds to 2 receptors;
angiotensin II receptor 1 (AGTR1) and angiotensin II receptor 2 (AGTR2) (29,
90). The vasoconstrictive (anti-natriuretic) effect of AT II is mediated through
AGTR1 while AGTR2 had been found to express an opposite effect (9, 12,
29). In a study conducted by Siragy et al on the function of AGTR2 in mice,
they infused AGTR2 null mice with AT II for 1 week and found exaggerated
anti-natriuretic effect characterized by sustained BP elevation and sodium
retention. The wildtype mice however, had no changes in BP and urinary Na+
(90). Padia et al further proposed from their study that AT II produces a
natriuretic effect in the absence of AGTR1 and that to activate this effect,
AGTR2 does not bind directly to AT II but to its metabolite – des-aspartyl1AngII (71). This is similar to the findings from the study conducted by Siragy et
al, suggesting that AGTR2 regulates BP by enhancing urinary sodium
excretion (natriuresis) (9, 90).
Aldosterone significantly increases sodium reabsorption along with potassium
secretion, mainly in the DCT and collecting duct of the nephrons, but also in
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the gastrointestinal tract, sweat and salivary glands. This
reabsorption/retention of sodium is important in maintaining effective
circulating blood volume and normal blood pressure(61).
Pressure natriuresis (intrinsic renal control of arterial blood pressure)
Though not well understood by early researchers, hypertension was thought
to be related to a dysfunction of the renal system. The role of renal sodium
excretion in regulating arterial pressure remained rather vague, however, until
the early 20th century when Guyton articulated the idea that long-term blood
pressure regulation is complexly linked to renal excretory function (39, 40). A
principal system for long-term control of arterial pressure is the pressurenatriuresis mechanism, by which increased renal perfusion pressure results in
decreased sodium reabsorption and increased sodium excretion, with
resultant changes in extracellular fluid volume (ECFV). Renal perfusion
pressure directly controls sodium reabsorption in the proximal tubule. As renal
perfusion pressure increases, renal peritubular capillary hydrostatic pressure
(filtration) increases, with a resultant increase in renal interstitial hydrostatic
pressure (RIHP). With increased filtration from the capillaries, more fluid exits
into the renal interstitium thus, reducing sodium reabsorption and increasing
urinary sodium excretion(20, 46). Nitric oxide has been shown to mediate and
improve pressure natriuresis (37). Conversely, pressure natriuresis can
become impaired in the presence of sympathetic overdrive, endothelial
dysfunction, genetic mutations or renal abnormalities that increase sodium
reabsorption at the distal tubule or antinatriuretic mediators like endothelin, AT

16

II, or aldosterone (40, 41, 46, 100). It follows that a sustained increase in
blood pressure occurs if the pressure natriuresis response is impaired,
making hypertension a disease of the kidney (15, 43, 46, 61).
Dahl and Heine studied the pressure natriuresis relationship in isolated
kidneys of salt sensitive (SS) and salt resistant (SR) rats. Both groups were
fed sodium restricted and high salt diets at different times in the study and
they followed up with their blood pressure, urine volume and urinary sodium
excretion. Both groups sustained normal blood pressure while on a salt
restricted diet, while the SR rats on a high salt diet also remained
normotensive throughout the study. On the other hand, blood pressure
became progressively elevated in the SS rats fed a high salt diet. They found
that the pressure natriuresis mechanism was preserved in both groups before
the onset of hypertension but became depressed with sustained BP elevation
(31).
The pressure-natriuresis relationship is most often studied as a linear
relationship, which is a regression line of plots of renal perfusion pressure
against urine sodium excretion. The slope of this curve indicates the
sensitivity of the relationship (steeper means more sodium is excreted as RPP
rises), and the Y intercept of parallel curves indicates a curve shift to the left
(more sodium excreted at each RPP) or right (less sodium excreted at each
RPP). Spontaneously hypertensive rats (SHR) are known to have abnormal
pressure natriuresis, with a right shifted curve and a shallower slope (83).
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Treatment of Hypertension
Treatment is generally individualized, based on the severity of hypertension,
presence/absence of comorbidities, presence and/or risk of complications
especially end organ damage. If a patient’s BP is not well controlled after
lifestyle modifications (reduced salt intake, frequent exercise, limited/no
alcohol intake, increased fruits, and vegetable consumption), the clinician
resorts to drug treatment and/or surgical management, as required. Blood
pressure medications (antihypertensives) may also be the first management
option if the patient presents with severe or complicated hypertension.
Previously, monotherapy was adopted in the management of high blood
pressure, but with increasing incidences of resistant hypertension and
treatment failure, most patients are now placed on combination therapy.
Antihypertensive medications generally work by controlling cardiac output
through modification of heart rate or stroke volume, or by regulating vascular
resistance since BP is a product of cardiac output and peripheral resistance.
Antihypertensives that reduce heart rate include β-blockers and calcium
channel blockers (CCB). β-blockers inhibit β1 adrenergic receptors from
binding to adrenaline, thus reducing heart rate, contractility, and cardiac
output. Examples include Atenolol, Propranolol, Carvedilol. CCBs control BP
by inhibiting calcium entry through calcium channels. This effect on cardiac
muscles reduces the force of contraction and heart rate, while on the vascular
smooth muscle, it prevents vasoconstriction. Ultimately, CCBs reduce cardiac
output and cause a decrease in resistance. Examples of CCBs include
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Nifedipine, Amlodipine, Nicardipine. Another class of antihypertensive called
diuretics controls cardiac output by regulating blood volume. Diuretics inhibit
sodium reabsorption and favor sodium excretion from the kidneys thus
reducing circulating volume and stroke volume. They are the most common
first line antihypertensives because sodium regulation is key to the regulation
of blood volume and blood pressure and they have proven to be very effective
over the years. Hydrochlorothiazide, Furosemide, Amiloride, Spironolactone,
Indapamide are a few examples of diuretics.
The other antihypertensive class that regulates vascular resistance is known
as vasodilators. They include CCBs, angiotensin converting enzyme inhibitors
(ACEIs), angiotensin receptor blockers (ARBs), renin inhibitors, α-blockers,
and direct vasodilators. ACEIs work by preventing conversion of AT I to AT II
and inhibiting the vasoconstrictive effect of AT II. Examples are Lisinopril,
Captopril, and Enalapril. ARBs work like ACEIs but by blocking AT II from
binding to AGTR1 to cause vasodilation. ARBs include Losartan, Telmisartan,
and Valsartan. Renin inhibitors inhibit renin release and the only example
licensed so far is Aliskiren. α-blockers inhibit α1 adrenergic receptors
responsible for initiating smooth muscle contraction and examples include
Prazosin and Doxazosin. Antihypertensives like hydralazine and minoxidil are
known as direct vasodilators because they cause direct vasodilation on
smooth muscles (3, 5, 19, 50, 64).
Surgical interventions are also available and vary based on the secondary
causes. Angioplasty may be done to repair coarctation of the aorta,
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adrenalectomy for diseased adrenal gland, nephrectomy for end stage renal
disease or tumor, renal denervation and deep brain stimulation for resistant
hypertension (66, 86, 91)
Exercise and hypertension
Physical activity is a major modifiable factor that reduces one’s chances of
developing hypertension (74). The beneficial effects of regular exercise for the
promotion of health and prevention of diseases have been clearly shown.
Regular exercise helps to reduce blood pressure, lower the risk of heart
disease, and strengthen the heart. Other cardiovascular benefits of exercise
include improvement of blood flow and oxygen to the body tissues, and
control of body weight, with obesity also a risk factor for hypertension.
Exercise also improves sleep, mental health, and mood, and strengthens
bones and muscles (108). A meta-analysis conducted by Wahid et al. to
assess the relationship between physical activity and cardiovascular diseases
showed that the risks of cardiovascular events declined with increasing
physical activity. This suggests that even a minimal increase in physical
activity results in significant cardiovascular benefit (101).
The burden of hypertension-related cardiovascular disease has become more
worrisome as the incidence keeps increasing in children and adolescents.
Although primary hypertension in childhood is commonly associated with
obesity, it seems that other factors, such as dietary sodium intake and
exercise, also influence BP levels (93). Several studies support that
sympathetic nervous system imbalance, impairment of the physiological
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mechanism of pressure natriuresis, hyperinsulinemia and early vascular
changes are factors responsible for the early-onset development of
hypertension. Although restriction of dietary sodium has been shown as a
rational step in the prevention of hypertension in genetically predisposed
individuals, interventional studies show that regular aerobic exercise can
significantly reduce BP and reverse vascular changes in obese/hypertensive
patients (93). T-cell and macrophage accumulation in the kidneys seen in
cases of atherosclerosis and obesity are also known to impair the pressure
natriuresis relationship. T-cells stimulate release of inflammatory cytokines
which cause oxidative stress, renal injury and nephron loss resulting in renal
sympathetic overdrive. Increased sympathetic activity in turn shifts the
pressure natriuresis curve to the right (46). Obesity also disrupts pressure
natriuresis through direct compression of the kidneys by renal fat, increased
activation of RAAS, reduced natriuretic peptides and endothelial dysfunction
(40, 42, 55).The burden of hypertension-related cardiovascular disease has
become more worrisome as the incidence keeps increasing in children and
adolescents. Although primary hypertension in childhood is commonly
associated with obesity, it seems that other factors, such as dietary sodium
intake and exercise, also influence BP levels (93).
Endothelial dysfunction has also been described to play a key role in the
development of hypertension. The vascular endothelium secretes vasoactive
substances including nitric oxide (NO), a potent vasodilator which maintains a
basal dilated tone of the blood vessels and promotes natriuresis and diuresis
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(67, 87, 92). NO has also been found to protect against plaque formation.
Damage or dysfunction of the endothelium, therefore, reduces NO release
which causes an increase in peripheral resistance, reduced blood flow, and
elevated blood pressure [17]. Reduced NO has also been shown to shift the
pressure natriuresis curve to the right (56).
Exercise has been associated with increased release of nitric oxide. Maiorana
et al in a study on the relationship between exercise and nitric oxide,
documented that individuals with previous endothelial dysfunction had
improved dilation of blood vessels when they exercised regularly. The
improvement manifested as a systemic reduction in total peripheral resistance
rather than a local vasodilation of the exercised muscle or group of muscles
(62). This suggests a mechanism of the relationship between exercise and
lower blood pressure as there is increased blood flow to the renal interstitium
which stimulates the pressure natriuresis mechanism.
Exercise has been shown to improve outcomes in hypertensive patients
evidenced by reducing heart rate, improving blood flow and oxygen extraction.
A study conducted on the effect of long-term exercise on the RAAS pathway
showed that fractional sodium excretion improved in exercised hypertensive
rats. This was attributed to reduced AGTR1 expression and increased urinary
Na+ excretion in the exercised rats (14). Goessler et al also demonstrated
that renin level is reduced with exercise training, thus reducing the levels of
AT II and aldosterone (32). Finally, exercise improved urine sodium excretion
in rats with congestive heart failure in a study conducted by Zheng et al (110).
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Numerous professional organizations recommend exercise as an initial
lifestyle therapy to prevent, treat, and control hypertension. Exercise is now
prescribed in terms of frequency, duration, and intensity. The popular
recommendation is moderately intense aerobic exercise (such as walking,
running, cycling, swimming), lasting for an average of 30 minutes per session
and at least 3-4 days per week (104). According to the latest physical activity
guidelines for Americans, adults are encouraged to engage in at least 2.5
hours of moderately intense aerobic exercise per week or at least 75 minutes
of vigorous exercise per week (28, 75). A review article published by Patel et
al, however, shows that aerobic exercise is effective for cardiac remodeling
while both aerobic and anerobic exercises can improve high density
lipoprotein and reduce low density lipoproteins and triglycerides (72). Findings
from an aerobic exercise study conducted on older patients with resistant
hypertension also showed up to 6mmHg reduction in systolic blood pressure
(18).

Background
Despite numerous studies on hypertension, more research is necessary for
improved understanding and management of this disease. Currently, the
mechanisms by which exercise lowers blood pressure or prevents
hypertension are not fully understood. In addition, the mechanism by which
exercise in children and adolescents, reduces the risk of later hypertension
development, is unclear. Furthermore, effects of exercise on urine sodium

23

excretion have been investigated in rats with congestive heart failure or
hypertension, but the effect on the pressure natriuresis relationship in normal
rats has not been reported. This study examined the effects of exercise in
young, growing rats on the pressure natriuresis relationship, once they reach
adulthood.

Problem statement
Since exercise is recommended as a non-pharmacological approach to
managing hypertension, and much more as an important factor for preventing
hypertension, understanding the mechanism of this effect is critical. Pressure
natriuresis is known to be altered in hypertension and is believed to contribute
significantly to the rise in mean arterial pressure. Therefore, this research
investigated in normotensive male and female rats, the relationship between
exercise during growth and development, and pressure natriuresis, to observe
effects of exercise in the absence of underlying disease.
Hypotheses
1. Exercise in rats during growth and development will improve the
pressure natriuresis relationship as adult rats.
2. Exercise will have a greater effect on pressure natriuresis in females
than males.
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Previous work
Rats are an acceptable model for the study of hypertension because they
have similar cardiovascular systems and mechanisms of blood pressure
control as found in humans (57).
Previous studies conducted in this laboratory on SHR (Spontaneously
Hypertensive Rats) and WKY (Wistar-Kyoto Normotensive rats) showed that
exercised rats excreted more urinary sodium when blood pressure was
raised, suggesting that exercise might modify how the kidney responds to
blood pressure. The surgical manipulation was, however, not tightly regulated,
hence, there was significant variation in the renal perfusion pressures across
the study groups. Furthermore, the study did not investigate the sodium
excretion in response to a lowered blood pressure. The current study carefully
regulated the increase in blood pressure, and added a decrease in blood
pressure, measured sodium excretion, and the change in sodium excretion, at
each level to produce a pressure-natriuresis curve for each group.

Materials and Methods
Forty normotensive male and female Wistar Kyoto (WKY) rats were weaned
at 4 weeks, then randomly assigned to the exercise or sedentary (control)
group. Rats were housed in standard plastic cages with corn cob bedding,
given standard rat chow and water ad libitum, and kept at 22o C with a 12:12
light cycle.
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Control/sedentary group: 8 male (8 Sed M) and 8 female (Sed F) rats were
housed individually with no exercise wheel for 8-10 weeks.
Exercise group: 10 male (EX M) and 10 female (Ex F) rats were housed
individually in a cage with an exercise wheel for 8 to 10 weeks. The exercise
wheel was connected to a counter which monitored the number of wheel
revolutions. This counter was read, recorded, and reset twice weekly.
Antibiotics: Early in the study, several rats developed respiratory distress
during anesthesia and died. Necropsy revealed pneumonia, commonly due to
an opportunistic bacterium, Pneumocystis (carinii or wakefieldiae). To prevent
the pneumonia, all rats in both the control and exercise groups were
subsequently placed on antibiotics for the first 10 days of the study.
Trimethoprim/Sulfamethoxazole was added to their drinking water to deliver a
dose of 50mg trimethoprim/250mg sulfamethoxazole /kg per day. The
average rat weight at set up period was about 200g (0.2 kg) and each drank
about 50mls of water per day. Based on the weight and the quantity of water
consumed per day, each treated rat received a daily dose of 60mg (1.25mls)
of antibiotics in 50mls of drinking water.

Surgical Setup
At the end of the sedentary or exercise period, the rats were ready for
surgery. Each rat (13-15 weeks of age) was anaesthetized with 3% isoflurane
in oxygen, and once asleep, dosed with intraperitoneal Inactin, at a dose of
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100mg/kg. Inactin became unavailable for part of the study, therefore, eleven
rats (5 sedentary males, 1 exercised female, 5 sedentary females) were
dosed with a different combination of intraperitoneal anesthetics – Tilzolan
and Xylazine. After several adjustments, the most effective dose was
determined to be 20mg/kg and 0.5mg/kg for Tilzolan and Xylazine,
respectively, with 25% of the initial dose given intraperitoneally as needed to
maintain anesthetic depth. The other 75% is given deep into the thigh muscle.
If a repeat dose was required, the rat was given 20% of the initial
intramuscular dose, as required.
Each rat was shaved on the ventral surface from the neck to the caudal
abdomen, and along the inner thighs. The rat was then placed on a heating
pad, in dorsal recumbency. A rectal temperature probe was inserted to
monitor the rat’s temperature, and the heating pad adjusted to keep
temperature at 37oC.
Next, a tracheal tube (PE 240) was inserted directly into the trachea to aid
respiration as rats breathe poorly when anaesthetized. The carotid and
femoral arteries were isolated and catheterized with heparin/saline (0.3ml
heparin/50 ml saline) filled PE 50 and PE 20 tubing, respectively. Tubing was
connected to stopcocks and both arterial catheters were connected to
pressure transducers which interfaced with a computer using physiological
software (BIOPAC). The jugular vein was also catheterized with saline filled
tubing (PE 50) attached to a stopcock for the infusion of saline at a rate of
20ml/kg/hr.
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The abdomen was opened, a thermometer probe placed within the abdomen
to determine abdominal temperature more accurately, and the temperature
was kept between 35oC – 36oC. (The open abdominal cavity resulted in an
artificially low temperature reading from the rectal probe.) The celiac and
mesenteric arteries were isolated near their origin, and a thread placed
around each artery and pulled through plastic tubing (PE 160) for later
tightening to raise renal perfusion pressure. The aorta was isolated above and
below the renal arteries and the tips of a forceps passed through an
adjustable bulldog clamp were placed with one prong either side of the aorta
above the renal arteries. The apex of the bladder was incised and a tube (PE
240) with a lip flamed on one side placed in the lumen and tied in place with
suture.
Exposed abdominal organs were covered with wet saline sponges and
wrapped in plastic, then the rat was allowed to stabilize for a 45-minute
equilibration period. Tuberculin syringes with the tips cut off, were labeled as
urine tubes to collect and record urine volumes. After the equilibration period,
the computer recording continued throughout the rest of the acute study. A
total of seven, 15-minute, urine collection periods were utilized – two at
baseline, two at the lower blood pressure (20 mmHg below baseline), and
three at a higher blood pressure (30 mmHg above baseline).
After the two baseline periods, the bulldog clamp was slowly tightened to
constrict the forceps on the aorta (above the renal artery) until the femoral BP
was 20mmHg below the animal’s baseline BP. Two 15-minute urine samples
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were collected and recorded. This gave the manipulated low value BP. To
raise blood pressure, the string ends protruding through the tubes on the
celiac and mesenteric arteries were tightened and clamped to raise blood
pressure by trapping additional blood in the aorta. In addition, the forceps was
moved to the aorta, below the renal arteries, and tightened until blood
pressure reached 30mmHg above the animal’s baseline BP. This produced
the high value. Three 15-minute urine samples were collected.
The combination anesthesia (Tilzolan/Xylazine) raised the baseline mean
arterial pressure in the rats approximately 30 mmHg above that of the Inactin
treated rats. To maintain consistency between these two anesthetics, the
“baseline value” was used as the “high value”. The renal perfusion pressure
was lowered by closing the forceps above the renal arteries until pressure
reached the mean Inactin baseline value of approximately 100 mmHg, and
this was used as the baseline value. The low value was then set 20 mmHg
lower (80mmHg) and was attained by further tightening the forceps on the
aorta above the renal artery.
Urine preparation and sodium analysis
Urine volumes were measured to the nearest 0.01ml, covered with parafilm,
and stored at 10 o C until analysis by flame photometer. During analysis, each
urine sample less than 0.15 ml was diluted to a volume of 0.30 ml with DDI
water to ensure an adequate sample size. Any sample greater than 0.15 ml
was diluted to twice the original volume so the sodium concentration did not
exceed that recommended by the operations manual of the flame photometer.
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Following the directions for the flame photometer, each of the samples was
further diluted to 1:200 and analyzed in duplicate. Total sodium excretion in
each 15-minute period was calculated by multiplying the average sodium
concentration in each sample by the urine volume for that period. The
concentration of sodium was adjusted for weight (sodium excretion per
kilogram body weight per 15 minutes) and changes in urine volume and
sodium excretion from baseline were also calculated.

Data Analyses
18 male and 18 female WKY rats were studied and randomly assigned to
exercise or sedentary treatment groups (8 sedentary males (Sed M), 8
sedentary females (Sed F), 10 exercised males (EX M) and 10 exercised
females (Ex F)). Two rats from the initial sedentary male group, and two from
the sedentary female group were discarded, due to the erratic outcomes from
changing anesthetic drugs - the baseline urinary sodium excretion was
extremely high (up to four times the highest baseline urinary sodium
excretion), hence the non-uniform sample size between the control and
treatment groups.
The renal perfusion pressures (RPP) were measured using the BIOPAC
software, and the data was transferred to an Excel spread sheet. The means
and standard errors of the RPP for each collection period were calculated.
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Sigma Plot 12.5 program was used for statistical analysis. A one-way ANOVA
was used to compare body weights, ages at the acute study, acute study
duration, saline infusion rate, and kidney weights. A two-way repeated
measure ANOVA was used to compare RPP, urine volumes, and urine
sodium excretions, and change in each value from baseline, within each
group, and between groups. Results of each manipulation were averaged,
and the average data analyzed using a two-way repeated measure ANOVA.
In a similar manner, change from baseline data was averaged for each
manipulation and analyzed. Holm-Sidak post hoc test was carried out for
multiple comparison of periods and groups.
A pressure natriuresis curve was created for each group by plotting urine
sodium excretion against RPP for each rat and generating a linear regression
line. Slopes and Y intercepts were compared between groups using Sigma
Plot software.
Statistical significance was accepted when p<0.05.

Results
General data
No differences were found between any rat groups in age, length of time of
acute study, saline flow rate, hematocrit, kidney weight or body weight, except
the male rat kidney and body weights which were greater than the female rats
(p < 0.05) (Table 1).
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Exercise
Male and female rats ran similar weekly distances throughout the duration of
the exercise weeks, except for week 4, during which the female rats ran a
greater mean distance than the males (Figure 1).
Renal Perfusion Pressure (RPP)
a) RPP data
For all groups, the lowered and raised RPP values were significantly
different (p<0.001) than baseline, and high values were different than
low values. The EX M group had significantly lower (p < 0.05) baseline
values (99±4 vs 107±3, and 100±3 vs 106±3 for baseline 1 and
baseline 2 respectively) and lower values for both low periods (77±3 vs
87±3 for both low periods) than the Sed M group (Figure 2). No
differences were found in RPP between the exercised and sedentary
females.
b) Mean of the RPP for each manipulation
The average of the RPP values for each manipulation was plotted for
all subgroups. The mean baseline and low values remained
significantly lower (p=0.021, p=0.039 respectively) in Ex M than Sed M
(Figure 3). No differences were found between the exercise and
sedentary females.
c) Mean RPP changes from baseline (∆RPP) for each manipulation
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For this analysis, the change in RPP (∆RPP) from baseline to the low
or to the high values were averaged for each manipulation in all groups
and plotted against their respective manipulations. No significant
difference in mean ∆RPP was observed between Ex M and Sed M
values. There was also no significant difference between Ex F and Sed
F mean ∆RPP values across all period manipulations (Figure 4).
Urine Volume
Urine volumes in both exercise groups increased significantly over both
baseline and low RPP values during all high RPP periods (p < 0.05). In the
sedentary groups, urine volume was significantly increased over the low RPP
periods during all high periods but was only significantly greater than baseline
during high 3 in the males, and high 2 and 3 in the females (p < 0.05).
Exercised males had a significantly higher urine volume than the sedentary
males during the second raised RPP period (high 2) (p = 0.036). No sex
difference in urine volumes was found between the male and female
sedentary groups, or the exercised groups (Figure 5).
Urine sodium (Na+) excretion
a) Na+ excretion
Sodium excretion was significantly increased (p <0.05) above both
baseline and low values when RPP was raised in the exercised male
and female rats (Ex M and Ex F) (Figure 6). However, in the sedentary
groups, sodium excretion was significantly elevated (p < 0.05) above
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baseline and low values only during the third period of raised RPP
(high-3) (Figure 6).
Exercised males had a significantly greater (p < 0.05) urine sodium
excretion than sedentary males during the second and third periods of
raised RPP (high-2 and high-3). No between group differences in Na+
excretion were found in the female rats, and no sex differences were
observed between the exercised males and females, or the sedentary
males and females.
b) Means of Na+ excretion for each manipulation
The average Na+ excretion was calculated for each manipulation.
Urine Na+ excretion was significantly greater in the high RPP periods
of exercised males and, sedentary and exercised females when
compared to baseline and low values (p < 0.05). In Sed M, the Na+
excretion was not significantly altered by any manipulation.
Comparison of Na+ excretion between the groups showed that the
exercised males had a greater sodium excretion during elevated RPP
(high) than the sedentary males (Figure 7).
c) Means sodium excretion changes from baseline (∆ Na+ excretion) for
each manipulation
The mean ∆Na+ excretion was calculated for each manipulation and is
shown in Figure 8. The change in sodium excretion during the high
RPP was significantly different than the change during the low RPP in
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sedentary females, and exercised males and females (p < 0.05). The
change in sodium excretion during high RPP was significantly greater
in the Ex M compared to that of Sed M (p=0.0041) (Figure 8) but no
significant differences were found between the female groups.
Pressure natriuresis curves
Exercise had a significant effect on the pressure natriuresis curve in both
male and female rats. The slope of the curve was greater in the exercised
male rats than in the sedentary male rats (2.07 vs 0.79, p = 0.01) and in the
exercised female rats than the sedentary female rats (3.49 vs 1.81, p=0.04)
(Figures 9 and 10). A sex difference was observed in the pressure natriuresis
curves, with sedentary female rats having a lower y-intercept than the
sedentary males (-132 vs –53; p=0.039), and the exercised females having a
greater slope than the exercised males (p=0.041) (Figure 11).

Discussion
There were no significant differences in general data between the groups. The
exercised and sedentary rats of the same sex had similar body and kidney
weights, however male rats had higher body weights and kidney weights than
females. Hematocrit and rate of saline infusion was also not significantly
different between the groups which indicates similar level of hydration.
Within groups, all raised and lowered RPP values were significantly different
from baseline values. The finding was similar when means of each
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manipulation were compared to baseline, indicating that the induced changes
in RPP were adequate. Between group comparisons showed that Ex M had
significantly lower baseline and lowered RPP manipulation than the Sed M but
found no difference between the female groups. The blood pressure lowering
effect of exercise has been previously described and may have been
responsible for this difference between the male groups, but this is unclear
when dealing with anesthetized rats (102). The lack of difference in baseline
RPP between the female groups may have been due to a sex difference in
the effects of exercise, or simply the effects of general anesthetic.
The change in RPP from baseline for both the low and high manipulations
was similar between the groups, indicating that the manipulated change in
values were of similar magnitudes. This assures a consistent RPP change in
determining the associated urine sodium excretion and avoids the potential
complications of a non-linear pressure natriuresis relationship that may be
evident only at greater distances from baseline.
Urine volumes and sodium excretion changed as expected, with changes in
RPP resulting in parallel changes in urine volume and sodium excretion. It is
well established that diuresis accompanies increases in RPP and natriuresis
(36). Urine volumes were similar between groups, with one exception during
high-2, when exercised males had a greater volume than sedentary males.
There were no significant differences between Na+ excretion at the baseline
RPP or at the lowered RPP across all groups. It is important to note that both
male and female rats, exercised and sedentary, had measurable pressure
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natriuresis responses, excreting more sodium into the urine as RPP was
raised. The effect was also amplified in the exercised groups as high RPP
manipulations resulted in significantly greater urinary Na+ excretion compared
to the sedentary groups, even though the change in RPP from baseline was
similar. This greater sodium excretion during the high RPP manipulations
was significant only in the males, with the exercised male rats excreting
significantly more sodium than the sedentary. The exercised females had a
higher mean Na+ excretion than the sedentary females when RPP was
raised, but this was not significant, likely affected by the large standard error.
There was also no statistical sex difference in urine sodium excretion between
males and females of the same treatment group.
Due to the large variation in baseline sodium excretion, change from baseline
was calculated for all rats for each manipulation. Exercised male rats had a
greater increase in urine sodium excretion when RPP was raised, than the
sedentary males. Although the exercised female rats had a larger mean
increase in sodium excretion during the high RPP manipulations, this was not
significant, again, likely influenced by the large standard error.
A pressure natriuresis curve was created for each group and compared
between the groups for statistical differences. The steeper slopes found in
both male and female exercised rats when compared to the respective
sedentary groups, indicates an improved sensitivity of the kidney to changes
in RPP. Exercise resulted in a greater increase in urine sodium excretion for
any given increase in RPP. Sex differences in the pressure-natriuresis
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relationship were found as well, with the female rats showing a more sensitive
renal sodium response to RPP changes than the male rats of the same
treatment group. Although the slope for the sedentary groups was not
statistically different, the slope difference resulted in a more negative yintercept in the female, than in the male rats. The greater slope in the
exercised females when compared to the exercised males indicates a greater
increase in urine sodium excretion for any increase in RPP. Thus, it appears
that female rats have a stronger pressure-natriuresis response.
The changes in the kidney induced by exercise are not well defined but some
theories have however been proposed. Exercise improves endothelial
function including greater nitric oxide (NO) production. This could result in a
greater medullary blood flow and capillary hydrostatic pressure, resulting in a
greater interstitial pressure that inhibits sodium reabsorption (56). Regular
physical activity has been shown to improve shear stress, which in turn
increases NOS activity. NO induces vascular remodeling and improves blood
flow (26). Exercise also resulted in improved urine sodium excretion and
increased sympathoinhibition, in response to blood volume expansion in rats
with heart failure in the study by Zheng et al. The authors suggested that
exercise may have improved the weak natriuresis effect in the rats with
cardiac failure through 2 mechanisms. There is improved neuronal release of
NO with prolonged exercise, which may be responsible for increased
inhibition of renal sympathetic activity. They also explained that plasma level
of AT II which intensifies sympathetic nervous stimulation, is reduced with
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exercise training (110). Waldman et al also demonstrated that exercise
improved sympathoinhibition and reduced AT II hypertensive rats to levels
similar to those of normotensive rats (102).
Studies have shown that female sex hormones, especially estrogen, have
protective cardiac and renal properties (53, 105, 106). A study conducted by
Ji et al showed that estrogen inhibits oxidative stress by suppressing reactive
oxygen species (ROS) (68, 107). Estrogen also regulates RAAS by reducing
renin levels and angiotensin converting enzyme (ACE) activity, thus inhibiting
sympathetic activity and preventing sodium retention (68, 107). Conversely,
testosterone is associated with increased secretion of renin and
angiotensinogen (54, 81). Nitric oxide is also increased in females due to
upregulation of nitric oxide synthase (NOS) activity by estrogen (63, 105).
Thus, the stronger pressure natriuresis relationship observed in females was
due to the sex hormone difference and not necessarily the effect of exercise.
Since sympathetic overdrive, RAAS activation and endothelial dysfunction are
factors shown to impair pressure natriuresis, exercise may modulate these
factors resulting in improved pressure natriuresis.

Conclusion
This study sought to demonstrate that effects of exercise on blood pressure
may be due to an effect on the pressure natriuresis relationship of the
kidneys. The findings clearly demonstrate that exercise improves the
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pressure natriuresis relationship in both male and female rats, supporting our
first hypothesis. However, we did not see a greater effect in female rats than
males (second hypothesis) but did find that the pressure natriuresis
relationship in female rats is more sensitive than that of males. Since
sympathetic overdrive, activation of RAAS and endothelial dysfunction are
factors that have been shown to impair pressure natriuresis, this study
therefore supports that exercise may modulate those factors resulting in
inhibition of sympathetic activity and RAAS as well as increased secretion of
NO.

Future Research
We have an ongoing study on the effects of exercise on pressure natriuresis
in hypertensive rats and we would also like to study the exact mechanisms by
which exercise improve pressure natriuresis.
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Tables and Figures
Table 1: General data from rats
Group

Age

Acute

Flow Rate

Hematocrit

Kidney

Body

(wks)

Study Total

(ml/kg/hr)

(%)

Weight

Weight

(g)

(kg)

Time (hr)

Sedentary

15.6 ±

Males

0.6

Exercised

15.2 ±

Males

0.6

Sedentary

17.6 ±

Females

1.3

Exercised

15.0 ±

Females

0.8

5.72 ± 0.37

20.76 ±

58.5 ± 1.88

1.24
6.01 ± 0.35

19.17 ±

58.6 ± 1.2

0.49
5.65 ± 0.20

21.36 ±

49.4 ± 3.3

0.27
5.34 ± 0.20

20.91 ±
0.48

52.1 ± 3.3

2.85 ±

0.397 ±

0.10*

0.011*

2.98 ±

0.384 ±

0.14*

0.013*

1.99 ±

0.254 ±

0.10

0.011

1.98 ±

0.259 ±

0.08

0.008

* p < 0.05 when compared to the female rats of the same treatment
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Running Distances
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Figure 1: Mean weekly running distances in male and female rats. † p <
0.05 when compared to the male rats during the same week.
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Renal Perfusion Pressure

Renal Perfusion Pressure
(mmHg)
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Manipulation of Renal Perfusion Pressure

Figure 2: Renal perfusion pressure (RPP) during baseline (BL), lowered
(low), and raised (high) manipulations in sedentary and exercised male and
female rats. † p < 0.05 when compared to the same period in the sedentary
rats of the same sex.
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Renal Perfusion Pressure - Mean of Each Manipulation
Mean Change in Renal Perfusion Pressure
160
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Figure 3: Mean renal perfusion pressure during baseline (BL) lowered (low)
and raised (high) manipulations in sedentary and exercised male and female
rats. † p < 0.05 when compared to the same period in the sedentary rats of
the same sex.
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Mean Change in Renal Perfusion Pressure
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Figure 4: Mean change from baseline in renal perfusion pressure during
lowered (low) and raised (high) manipulations in sedentary and exercised
male and female rats.
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Urine Volume
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Figure 5: Urine volume during baseline (BL), lowered (low), and raised (high)
manipulations of renal perfusion pressure in sedentary and exercised male
and female rats.
*p < 0.05 when compared to either baseline value.  p < 0.05 when
compared to either low value. † p < 0.05 when compared to the same period
in the sedentary rats of the same sex.
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Figure 6: Urine sodium excretion during baseline (BL), lowered (low), and
raised (high) manipulations of renal perfusion pressure in sedentary and
exercised male and female rats.
*p < 0.05 when compared to either baseline value.  p < 0.05 when
compared to either low value. † p < 0.05 when compared to the same period
in the sedentary rats of the same sex.
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Figure 7: Mean urinary sodium excretion during baseline (BL) lowered (low)
and raised (high) manipulations in sedentary and exercised male and female
rats.
*p < 0.05 when compared to baseline value.  p < 0.05 when compared to
low value. † p < 0.05 when compared to the same period in the sedentary
rats of the same sex.
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Figure 8: Mean change from baseline in urine sodium excretion during
lowered (low) and raised (high) manipulations in sedentary and exercised
male and female rats.
 p < 0.05 when compared to low value. † p < 0.05 when compared to the
same period in the sedentary rats of the same sex.
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Figure 9: Pressure natriuresis curves in sedentary and exercised male rats.
† p < 0.05 when the slope is compared to that of the sedentary rats.
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Figure 10: Pressure natriuresis curves in sedentary and exercised female
rats. † p < 0.05 when the slope is compared to that of the sedentary rats.
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†

Figure 11: Pressure natriuresis curves in sedentary and exercised, male and
female rats. † p < 0.05 when the slope of the female rats is compared to that
of males of the same treatment.  p <0.05 when the y-intercept of the female
rats is compared to that of males of the same treatment.
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